Amal Therapeutics, a Swiss biotech start-up company developing and progressing therapeutic vaccines in oncology, announced that it received a grant from the Swiss Commission for Technology & Innovation (CTI). The grant will allow Amal to evaluate promising immunotherapy combination treatments.
Success stories and tips from startup experts are always a considerable input for startups. This press review provides a short insight into the current status of the Swiss startup scene through highlighting a few success stories and tips from experts.
After finalizing its annual financial statements for 2015, GeNeuro, a biopharmaceutical company based in Geneva developing new treatments for autoimmune diseases including multiple sclerosis (MS), has today reaffirmed its plan to raise capital through an initial public offering on the regulated market of Euronext’s in Paris.
Der Swiss Export Award ist das Oscar der Schweizer Exportindustrie. Die unabhängige Jury aus Wirtschafts-, Wissenschafts- und Medien-Vertretern hat die Finalisten für den Export Award 2016 bekannt gegeben, darunter ist auch das Zürcher startup Swiss Eyewear Group in der Kategorie Success.
Last week, the determination of the Top 100 European Fintech startups was left in the hands of the jury and the audience from Europe. The Top 100 list has been published and among the selected companies are six Swiss startups with Knip and NetGuardians in the top three of their categories. They will pitch at the European FinTech Awards & Conference in Amsterdam on the 14th of April.